Clinical Trials
129 trialsExtracellular RNA Markers of Liver Disease and Cancer
Mayo Clinic
Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC
RenJi Hospital
NOLA (NeuWave Observational Liver Ablation) Registry
Ethicon, Inc.
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
M.D. Anderson Cancer Center
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
National Institutes of Health Clinical Center (CC)
PLATON
Institut fĂĽr Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Liver and Biliary Tumor Tissue Registry
Mayo Clinic
A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery
University of Washington
Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract
American Regent, Inc.
PANORAMA
Techsomed Medical Technologies LTD
Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)
Eureka Therapeutics Inc.
18F-DCFPyL PET/CT in Hepatocellular Carcinoma
National Institutes of Health Clinical Center (CC)
MODELS
UniversitĂ Vita-Salute San Raffaele
STOP-HCC
Johns Hopkins University
Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
LEO Pharma
Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma
LEO Pharma
ABT-888 and Temozolomide for Liver Cancer
Georgetown University
MYCHELANGELO I
Omega Therapeutics
Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy
M.D. Anderson Cancer Center
EQLVCPAL
Centre Hospitalier de la cĂ´te Basque
LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors
National Institutes of Health Clinical Center (CC)
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Pfizer
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors
Pfizer
e:Med-HCC-2
University Hospital Tuebingen
Ultrasound Monitoring of Abdominal Soft Tissue
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
iEXMachyna3
IHU Strasbourg
Ablation Confirmation Study
Ethicon, Inc.
A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours
Fusion Pharmaceuticals Inc.
Utilization of MAsS in Patients Undergoing LT for HCC
Columbia University
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer
Canadian Cancer Trials Group
Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI
American College of Radiology
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
City of Hope Medical Center
Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE
H. Lee Moffitt Cancer Center and Research Institute
CheckMate 76U
Bristol-Myers Squibb
SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
ABLATE
Imunon
ET-109
Eureka Therapeutics Inc.
Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms
National Institutes of Health Clinical Center (CC)
Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
Washington University School of Medicine
MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma
Big Ten Cancer Research Consortium
Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma
BTG International Inc.
PATRON
Cellxpert Biotechnology Corp.
Feasibility of Ultrasound-based Navigation for Non-anatomical Liver Resections
Insel Gruppe AG, University Hospital Bern
Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases
Wake Forest University Health Sciences
Liver Regeneration
University Health Network, Toronto
EXALT
Milton S. Hershey Medical Center
ReDos HCC
SC Liver Research Consortium, LLC
A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver
University of California, San Diego